Decreased Dopamine Activity in Brain Leads to ADHD in Adults

by VR Sreeraman on August 7, 2007 at 5:34 PM
Decreased Dopamine Activity in Brain Leads to ADHD in Adults

A new study has linked Attention Deficit Hyperactivity Disorder (ADHD) in adults with depressed dopamine activity in the brain. The study showed a blunted response to the drug methylphenidate (Ritalin), which increases brain dopamine levels in ADHA patients.

Dopamine is a phenethylamine naturally produced by the human body, which acts as a neurotransmitter in the brain.


The study was conducted by a team of researchers led by Nora D. Volkow at the National Institute on Drug Abuse, Bethesda, Maryland.

As part of the study, researchers examined 19 adults with with ADHD (average age 32) who had never received medication and 24 healthy controls (average age 30) and performed brain scans using positron emission tomography (PET) and a drug known as raclopride labelled with carbon 11 ([11C]raclopride), which binds with dopamine receptors.

Researchers scanned the patients twice after injecting them with placebo and methylphenidate. The participants were asked to report the severity of their ADHD symptoms, whether they could detect the drug, if they liked or disliked it, and if it made them feel 'high', tired, alert, anxious or restless.

The study found that methylphenidate caused less of a decrease in the amount of [11C]raclopride that bound to dopamine receptors in areas of the brain associated with attention in individuals with ADHD.

Researchers suggested that since levels of methylphenidate in the blood were same in both groups, those with ADHD released less dopamine in response to the drug than controls. This blunted response was associated with symptoms of inattention.

"The findings of reduced dopamine release in subjects with ADHD are consistent with the notion that the ability of stimulant medications to enhance extracellular dopamine underlies their therapeutic effects in ADHD," the authors wrote.

The findings of the study were published in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Source: ANI
Font : A-A+



Recommended Readings

Latest Drug News

Anti-Obesity Drugs' Impact on Osteoarthritis Survival
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Decreased Dopamine Activity in Brain Leads to ADHD in Adults Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests